MI HB5598 | 2013-2014 | 97th Legislature

Status

Spectrum: Partisan Bill (Republican 2-0)
Status: Introduced on May 27 2014 - 25% progression, died in committee
Action: 2014-05-28 - Printed Bill Filed 05/28/2014
Pending: House Health Policy Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Health; pharmaceuticals; FDA-designated biosimilar drug products; allow substitution for brand-name drugs by pharmacists. Amends secs. 17702, 17704 & 17755 of 1978 PA 368 (MCL 333.17702 et seq.).

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health; pharmaceuticals; FDA-designated biosimilar drug products; allow substitution for brand-name drugs by pharmacists. Amends secs. 17702, 17704 & 17755 of 1978 PA 368 (MCL 333.17702 et seq.).

Sponsors


History

DateChamberAction
2014-05-28HousePrinted Bill Filed 05/28/2014
2014-05-27HouseReferred To Committee On Health Policy
2014-05-27HouseRead A First Time
2014-05-27HouseIntroduced By Representative Ken Yonker

Subjects


Michigan State Sources


Bill Comments

feedback